ABIVAX Société Anonyme AAVXF Stock
ABIVAX Société Anonyme Price Chart
ABIVAX Société Anonyme AAVXF Financial and Trading Overview
| ABIVAX Société Anonyme stock price | 101.25 USD |
| Previous Close | 101.25 USD |
| Open | 101.25 USD |
| Bid | 96.64 USD x 10000 |
| Ask | 106 USD x 10000 |
| Day's Range | 101.25 - 101.25 USD |
| 52 Week Range | 7.28 - 133.4 USD |
| Volume | 100 USD |
| Avg. Volume | 19 USD |
| Market Cap | 8.08B USD |
| Beta (5Y Monthly) | -0.2 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -5.29 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
AAVXF Valuation Measures
| Enterprise Value | 7.57B USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1641.6122 |
| Price/Book (mrq) | 16.123993 |
| Enterprise Value/Revenue | 1538.799 |
| Enterprise Value/EBITDA | -29.806 |
Trading Information
ABIVAX Société Anonyme Stock Price History
| Beta (5Y Monthly) | -0.2 |
| 52-Week Change | 1290.79% |
| S&P500 52-Week Change | 24.48% |
| 52 Week High | 133.4 USD |
| 52 Week Low | 7.28 USD |
| 50-Day Moving Average | 112.52 USD |
| 200-Day Moving Average | 110.25 USD |
AAVXF Share Statistics
| Avg. Volume (3 month) | 19 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 79.77M |
| Float | 58.23M |
| Short Ratio | N/A |
| % Held by Insiders | 5.30% |
| % Held by Institutions | 51.27% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -4183.70% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -44.65% |
| Return on Equity (ttm) | -157.067% |
Income Statement
| Revenue (ttm) | 4.92M USD |
| Revenue Per Share (ttm) | 0.07 USD |
| Quarterly Revenue Growth (yoy) | 35.19% |
| Gross Profit (ttm) | 4.92M USD |
| EBITDA | -254004000 USD |
| Net Income Avi to Common (ttm) | -332200000 USD |
| Diluted EPS (ttm) | -5.36 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 491.55M USD |
| Total Cash Per Share (mrq) | 6.2 USD |
| Total Debt (mrq) | 34.21M USD |
| Total Debt/Equity (mrq) | 7.96 USD |
| Current Ratio (mrq) | 8.247 |
| Book Value Per Share (mrq) | 6.279462 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -178370000 USD |
| Levered Free Cash Flow (ttm) | -114471872 USD |
Profile of ABIVAX Société Anonyme
| Country | United States |
| State | N/A |
| City | Paris |
| Address | 7-11 Boulevard Haussmann |
| ZIP | 75009 |
| Phone | 33 1 53 83 09 63 |
| Website | https://www.abivax.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 80 |
ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
Q&A For ABIVAX Société Anonyme Stock
What is a current AAVXF stock price?
ABIVAX Société Anonyme AAVXF stock price today per share is 101.25 USD.
How to purchase ABIVAX Société Anonyme stock?
You can buy AAVXF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ABIVAX Société Anonyme?
The stock symbol or ticker of ABIVAX Société Anonyme is AAVXF.
Which industry does the ABIVAX Société Anonyme company belong to?
The ABIVAX Société Anonyme industry is Biotechnology.
How many shares does ABIVAX Société Anonyme have in circulation?
The max supply of ABIVAX Société Anonyme shares is 79.69M.
What is ABIVAX Société Anonyme Price to Earnings Ratio (PE Ratio)?
ABIVAX Société Anonyme PE Ratio is now.
What was ABIVAX Société Anonyme earnings per share over the trailing 12 months (TTM)?
ABIVAX Société Anonyme EPS is -5.29 USD over the trailing 12 months.
Which sector does the ABIVAX Société Anonyme company belong to?
The ABIVAX Société Anonyme sector is Healthcare.